Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 01/28: (NEOS) (UA) (FB) Higher; (NOW) (OSIS) (EBAY) Lower (more...)

January 28, 2016 9:30 AM
Neos Therapeutics (NASDAQ: NEOS) 59% HIGHER; the U.S. Food and Drug Administration (FDA) approved Adzenys XR-ODT for the treatment of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles